← Eichor
Condition: Salivary Gland Carcinoma Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Salivary Gland Carcinoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

An International Study on Pediatric Patients With Rare Tumors.
Phase N/A · 1 location(s) · Azienda Ospedaliera di Padova · NCT07072143Adenoid Cystic Carcinoma and Carbon Ion Only Irradiation
Phase 2 · 1 location(s) · Heidelberg University · NCT04214366Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas
Phase 2 · 13 location(s) · Dana-Farber Cancer Institute · NCT04620187A Phase 2 Trial of Ivonescimab for Patients With Advanced, Metastatic Salivary Gland Cancers
Phase 2 · 2 location(s) · Glenn J. Hanna · NCT06805617Neoadjuvant Nivolumab, Docetaxel, Cisplatin Therapy Followed by Surgery and Radiation Therapy for Resectable High Grade
Phase 2 · 1 location(s) · Myung-Ju Ahn · NCT05727410Immune Biomarker Study for Salivary Gland Carcinoma
Phase N/A · 2 location(s) · University of Erlangen-Nürnberg Medical School · NCT06047236Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular Typing
Phase 2 · 2 location(s) · Peking Union Medical College · NCT06145308d-Limonene +Radiation +PlatinumBasedChemo for Xerostomia Prevention in LocallyAdvanced HNSCC
Phase 1 · 1 location(s) · Stanford University · NCT04392622Customized 3D Printed Oral Stents During Head and Neck Radiotherapy
Phase 2 · 7 location(s) · M.D. Anderson Cancer Center · NCT04870762Oropharynx (OPX) Biomarker Trial
Phase N/A · 1 location(s) · Mayo Clinic · NCT06356272DESTINY-PANTUMOUR04
Phase N/A · 18 location(s) · AstraZeneca · NCT07124000The Safety and Efficacy of MRG003 With or Without Putrelimab in Recurrent or Metastatic Salivary Gland Cancer: a Single-
Phase 2 · 1 location(s) · Ji Dongmei · NCT07464366Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Can
Phase N/A · 1 location(s) · University of Colorado, Denver · NCT00900419Drug Screening Using Novel IMD in Salivary and Head and Neck Cancers
EARLY_Phase 1 · 2 location(s) · Brigham and Women's Hospital · NCT05553782A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
Phase 1/Phase 2 · 8 location(s) · LigaChem Biosciences, Inc. · NCT05941507Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants
Phase N/A · 4 location(s) · Vanderbilt University Medical Center · NCT00898638A Multi-omics Approach to Disclose Progression and Underlying Biology of Head and Neck Adenoid Cystic Carcinoma
Phase N/A · 1 location(s) · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano · NCT07507578The Study on the Mechanism of Radiotherapy-elicited Immune Response
Phase N/A · 1 location(s) · Fudan University · NCT06393140Adjuvant Rezvilutamide in Combination With Androgen Deprivation Therapy in Androgen Receptor-positive, High-risk Salivar
Phase 2 · 2 location(s) · Peking University First Hospital · NCT06348264Agnostic Therapy in Rare Solid Tumors
Phase 2 · 8 location(s) · Instituto do Cancer do Estado de São Paulo · NCT06638931PDO Based Drug Sensitive Test in R/M SGC
Phase N/A · 2 location(s) · Huashan Hospital · NCT06686979Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objective
NA · 1 location(s) · M.D. Anderson Cancer Center · NCT01365169Objective Response Rate of Ivonescimab With Chemotherapy in Locally Advanced Resectable Oral and Oropharyngeal Squamous
Phase N/A · 2 location(s) · Zhujiang Hospital · NCT07686575Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors
Phase 1 · 1 location(s) · Baylor College of Medicine · NCT03740256Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzum
Phase 2 · 152 location(s) · NRG Oncology · NCT05408845The Head and Neck Registry of the European Reference Network on Rare Adult Solid Cancers
Phase N/A · 10 location(s) · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano · NCT05483374Integrated Cancer Repository for Cancer Research
Phase N/A · 42 location(s) · University of Nebraska · NCT02012699Sacituzumab Govitecan in Metastatic Salivary Gland and Thyroid Cancers (SG-SGTC)
Phase 2 · 1 location(s) · National University Hospital, Singapore · NCT06923826Prospective Registry Study on the Implementation of Simultaneous Postoperative Radiochemotherapy for Salivary Gland Carc
Phase N/A · 1 location(s) · University of Erlangen-Nürnberg Medical School · NCT06464198VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Phase 1/Phase 2 · 15 location(s) · VM Oncology, LLC · NCT03556228
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.